Baker Tilly Wealth Management, LLC Anavex Life Sciences Corp. Transaction History

Baker Tilly Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$5.04 - $9.95 $2,635 - $5,203	523 Added 2.08%	25,714 $239,000
Q3 2023 Oct 10, 2023	SELL	$6.55 - $9.37 $216 - $309	-33 Reduced 0.13%	25,191 $165,000
Q2 2023 Jul 20, 2023	BUY	$7.66 - $9.5 $116,615 - $144,628	15,224 Added 152.24%	25,224 $205,000
Q1 2021 Apr 28, 2021	SELL	$5.17 - $16.13 $51,700 - $161,300	-10,000 Reduced 50.0%	10,000 $150,000
Q4 2020 Feb 03, 2021	BUY	$4.01 - $7.58 $80,200 - $151,600	20,000 New	20,000 $108,000

154

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $581M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.